BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38853902)

  • 1. Mid-to-Late Life Healthy Lifestyle Modifies Genetic Risk for Longitudinal Cognitive Aging among Asymptomatic Individuals.
    Xu Y; Sun Z; Jonaitis E; Deming Y; Lu Q; Johnson SC; Engelman CD
    medRxiv; 2024 May; ():. PubMed ID: 38853902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E moderates the association between non-APOE polygenic risk score for Alzheimer's disease and aging on preclinical cognitive function.
    Xu Y; Sun Z; Jonaitis E; Deming Y; Lu Q; Johnson SC; Engelman CD
    Alzheimers Dement; 2024 Feb; 20(2):1063-1075. PubMed ID: 37858606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E moderates the association between Non-
    Xu Y; Sun Z; Jonaitis E; Deming Y; Lu Q; Johnson SC; Engelman CD
    medRxiv; 2023 Jun; ():. PubMed ID: 37398140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
    Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
    Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease.
    Porter T; Burnham SC; Savage G; Lim YY; Maruff P; Milicic L; Peretti M; Ames D; Masters CL; Martins RN; Rainey-Smith S; Rowe CC; Salvado O; Taddei K; Groth D; Verdile G; Villemagne VL; Laws SM
    Front Aging Neurosci; 2018; 10():423. PubMed ID: 30620773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low testosterone levels relate to poorer cognitive function in women in an APOE-ε4-dependant manner.
    Dratva MA; Banks SJ; Panizzon MS; Galasko D; Sundermann EE;
    Biol Sex Differ; 2024 Jun; 15(1):45. PubMed ID: 38835072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Unhealthy Lifestyle and Genetic Risk Factors With Mild Cognitive Impairment in Chinese Older Adults.
    Duan H; Zhou D; Xu N; Yang T; Wu Q; Wang Z; Sun Y; Li Z; Li W; Ma F; Chen Y; Du Y; Zhang M; Yan J; Sun C; Wang G; Huang G
    JAMA Netw Open; 2023 Jul; 6(7):e2324031. PubMed ID: 37462970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of APOE ε4 genotype and lifestyle with cognitive function among Chinese adults aged 80 years and older: A cross-sectional study.
    Jin X; He W; Zhang Y; Gong E; Niu Z; Ji J; Li Y; Zeng Y; Yan LL
    PLoS Med; 2021 Jun; 18(6):e1003597. PubMed ID: 34061824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between healthy lifestyle and memory decline in older adults: 10 year, population based, prospective cohort study.
    Jia J; Zhao T; Liu Z; Liang Y; Li F; Li Y; Liu W; Li F; Shi S; Zhou C; Yang H; Liao Z; Li Y; Zhao H; Zhang J; Zhang K; Kan M; Yang S; Li H; Liu Z; Ma R; Lv J; Wang Y; Yan X; Liang F; Yuan X; Zhang J; Gauthier S; Cummings J
    BMJ; 2023 Jan; 380():e072691. PubMed ID: 36696990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older population.
    Riaz M; Huq A; Ryan J; Orchard SG; Tiller J; Lockery J; Woods RL; Wolfe R; Renton AE; Goate AM; Sebra R; Schadt E; Brodtmann A; Shah RC; Storey E; Murray AM; McNeil JJ; Lacaze P
    Aging Cell; 2021 Jun; 20(6):e13384. PubMed ID: 34041846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score.
    Tomassen J; den Braber A; van der Lee SJ; Reus LM; Konijnenberg E; Carter SF; Yaqub M; van Berckel BNM; Collij LE; Boomsma DI; de Geus EJC; Scheltens P; Herholz K; Tijms BM; Visser PJ
    BMC Neurol; 2022 Dec; 22(1):484. PubMed ID: 36522743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study.
    van der Lee SJ; Wolters FJ; Ikram MK; Hofman A; Ikram MA; Amin N; van Duijn CM
    Lancet Neurol; 2018 May; 17(5):434-444. PubMed ID: 29555425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
    Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
    Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated cell aging in female APOE-ε4 carriers: implications for hormone therapy use.
    Jacobs EG; Kroenke C; Lin J; Epel ES; Kenna HA; Blackburn EH; Rasgon NL
    PLoS One; 2013; 8(2):e54713. PubMed ID: 23418430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOE ε4 carrier status and sex differentiate rates of cognitive decline in early- and late-onset Alzheimer's disease.
    Polsinelli AJ; Logan PE; Lane KA; Manchella MK; Nemes S; Sanjay AB; Gao S; Apostolova LG
    Alzheimers Dement; 2023 May; 19(5):1983-1993. PubMed ID: 36394443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of APOE status on cognitive maintenance in healthy elderly persons.
    Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention.
    Sager MA; Hermann B; La Rue A
    J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):245-9. PubMed ID: 16306248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the Apolipoprotein E ε4 Allele on the Relationship Between Healthy Lifestyle and Cognitive Decline: A Population-Based Study.
    Dhana K; Aggarwal NT; Rajan KB; Barnes LL; Evans DA; Morris MC
    Am J Epidemiol; 2021 Jul; 190(7):1225-1233. PubMed ID: 33585904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.